Enanta Pharmaceuticals logo

Enanta Pharmaceuticals

ENTA | NASDAQ
Chart Builder DCF Calculator
$10.67
-$0.32 (-2.91%)
At close: Nov 16, 2026, 4:00 PM ET
$10.99
+$0.32 (+3.00%)
After-hours: Nov 16, 2026, 7:34 PM ET
-2.91%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
43
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #446/1021 (Top 44%)

Key Statistics

Market Data

Market Cap $310.77M
1D Range
10.63 11.09
52W Range
10.08 16.85

Valuation (TTM)

PE -4.43
PB 3.07
EV/EBITDA -3.90

Valuation (NTM)

Forward PE N/A
Forward PEG 1.10
Price Target $20.00
Loading financial charts...

Profile

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its re...

Sector Healthcare
Industry Biotechnology
Employees 120
IPO Date Mar 21, 2013
Fiscal Year October - September

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 16, 2026
EPS
-$0.81
Miss -11.88%
REV
$12.86M
Miss -12.05%
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$20.00
Upside
+87.44%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.